» Articles » PMID: 35751106

Development of an Interdisciplinary Early Rheumatoid Arthritis Care Pathway

Abstract

Background: To develop an interdisciplinary care pathway for early rheumatoid arthritis (RA) including referral triage, diagnosis, and management.

Methods: Our process was a four-phase approach. In Phase 1, an anonymous survey was electronically distributed to division rheumatologists. This provided data to a small interprofessional working group of rheumatology team members who drafted an initial care pathway informed by evidence-based practice in Phase 2. In Phase 3, an education day was held with approximately 40 physicians (rheumatologists and rheumatology residents), members of our interprofessional team, and two clinic managers to review the proposed care elements through presentations and small group discussions. The care pathway was revised for content and implementation considerations based on feedback received. Implementation of the care pathway and development of strategies for evaluation is ongoing across multiple practice sites (Phase 4).

Results: Our care pathway promotes an approach to patient-centered early RA care using an interdisciplinary approach. Care pathway elements include triage processes, critical diagnostics, pre-treatment screening and vaccinations, and uptake of suggested RA pharmacologic treatment using shared decision-making strategies. Pathway implementation has been facilitated by nursing protocols and evaluation includes continuous monitoring of key indicators.

Conclusion: The 'Calgary Early RA Care Pathway' emphasizes a patient-centered and interdisciplinary approach to early RA identification and treatment. Implementation and evaluation of this care pathway is ongoing to support, highest quality care for patients.

Citing Articles

A theory of change for patient-initiated follow-up care in rheumatoid arthritis.

Ester M, White K, Dhiman K, Zafar S, Subdar S, Zimmermann G BMC Rheumatol. 2025; 9(1):31.

PMID: 40075469 PMC: 11899900. DOI: 10.1186/s41927-025-00481-3.


Effectiveness of General Medicine in the Management of Rheumatoid Arthritis in Rural Settings: A Systematic Review and Meta-Ethnography.

Ohta R, Sano C Cureus. 2024; 16(11):e73726.

PMID: 39677127 PMC: 11646328. DOI: 10.7759/cureus.73726.


Lifestyle discussions facilitate self-management in RA: a qualitative study of patients' perceptions.

Drake Af Hagelsrum K, Larsson I, Bremander A, Einarsson J, Lindqvist E, Mogard E BMC Rheumatol. 2024; 8(1):65.

PMID: 39609884 PMC: 11606137. DOI: 10.1186/s41927-024-00433-3.


Effectiveness of the re-engineered discharge (RED) care model in patients with rheumatoid arthritis.

Chen D, Zhou Q Medicine (Baltimore). 2024; 103(43):e39722.

PMID: 39470493 PMC: 11521066. DOI: 10.1097/MD.0000000000039722.


Management of Rheumatoid Arthritis in Primary Care: A Scoping Review.

Inchingolo F, Inchingolo A, Fatone M, Avantario P, Del Vecchio G, Pezzolla C Int J Environ Res Public Health. 2024; 21(6).

PMID: 38928909 PMC: 11203333. DOI: 10.3390/ijerph21060662.


References
1.
Taylor P, van de Laar M, Laster A, Fakhouri W, Quebe A, de la Torre I . Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis-going beyond treat to target. RMD Open. 2021; 7(3). PMC: 8666892. DOI: 10.1136/rmdopen-2021-001959. View

2.
Seys D, Coeckelberghs E, Sermeus W, van Zelm R, Panella M, Payedimarri A . Overview on the target population and methods used in care pathway projects: A narrative review. Int J Clin Pract. 2021; 75(10):e14565. DOI: 10.1111/ijcp.14565. View

3.
Connell A, Montgomery H, Martin P, Nightingale C, Sadeghi-Alavijeh O, King D . Evaluation of a digitally-enabled care pathway for acute kidney injury management in hospital emergency admissions. NPJ Digit Med. 2019; 2:67. PMC: 6669220. DOI: 10.1038/s41746-019-0100-6. View

4.
Soto G, Huenefeldt E, Hengst M, Reimer A, Samuel S, Samuel S . Implementation and impact analysis of a transitional care pathway for patients presenting to the emergency department with cardiac-related complaints. BMC Health Serv Res. 2018; 18(1):672. PMC: 6117924. DOI: 10.1186/s12913-018-3482-2. View

5.
Bombardier C, Hazlewood G, Akhavan P, Schieir O, Dooley A, Haraoui B . Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. J Rheumatol. 2012; 39(8):1583-602. DOI: 10.3899/jrheum.120165. View